Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Neurophth to Develop AAV Capsids with AAVnerGene for Ophthalmology

Gracell to Start China Trial of CAR-T in Leukemia Patients

Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL

Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies

JW Therapeutics Completes $300 Million Hong Kong IPO for CAR-T Products

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China